Somuncu and colleagues showed that patients with MI who had MMP-9 plasma levels above 12.92 ng/mL at the time of hospital admission had 3.5-fold higher odds for cardiovascular mortality and increased risk for advanced heart failure compared to the group with lower MMP-9 concentrations [24]. This evidence concerns the gene MMP9 and heart failure.